|
|
December 18,
2009
December 17,
2009
December 16,
2009
|
|
|
December 18,
2009
December 17,
2009
-
Daytrana
(methylphenidate)
Patch,Shire
Development,
Inc.,
Labeling
Revision
-
Verelan
PM (verapamil
hydrochloride)
Extended-Release
Capsules,
Elan
Drug
Delivery,
Inc.,
Labeling
Revision
December 16,
2009
-
Arranon
(nelarabine)
I.V.
Injection,
GlaxoSmithKline,
Labeling
Revision
-
Stromectol
(ivermectin)
Tablets,
Merck
and Co.,
Inc.,
Labeling
Revision
December 15,
2009
-
Hylenex
Recombinant
(hyaluronidase
recombinant
human)
Injection,
Halozyme
Therapeutics,
Inc.,
Labeling
Revision
-
Invanz
(ertapenem),
I.V.
Injection,
Merck &
Co.,
Inc.,
Labeling
Revision
-
Ranitidine
Hydrochloride
Tablets,
Wockhardt,
Approval
-
Zyprexa
Relprevv
(olanzapine)
Injection,
Eli
Lilly,
Approval
|
|
|
- FDA Orphan Drugs Workshops, February 25-26, 2010, Claremont, CA; August 3-4, 2010, Minneapolis, MN. Meeting Brochure (PDF - 91 KB)
- Indexing Labeling for Human Drug and Biological Products using Structured Product Labeling (SPL). February 2010.
- FDA/DIA 5th Workshop in a Series on Pharmacogenomics: Generating and Weighing Evidence in Drug Development and Regulatory Decision Making, February 2-4, 2010, Marriott Bethesda North Hotel and Conference Center, 5701 Marinelli Road, Bethesda, MD. Meeting Information and registration
- DIA/FDA CDER/CBER Computational Science Annual Meeting, March 22-23, 2010, Bethesda, MD. Meeting information and registration
- 4th Annual FDA/DIA Statistics Forum, April 19-21, 2010, Bethesda, MD. Meeting information and registration.
|
|
|
|
Guidance
Approved Drugs
Approval Process
Electronic Submissions
Firm Registration Status
Good Manufacturing Practice
Regulations
National Drug Code Directory
MedWatch: Adverse Event
Reporting
Download Forms
Generic Drugs
Small Business
En
Espaρol
|
|
|
|
|
|
|
|
|
|
|
|
|
About CBER
CBER Vision & Mission Biologics Research, Regulatory Information, Safety & Availability, Guidances, Development & Approval, Enforcement & Compliance
News & Events (Biologics) What's New, Meetings & Workshops
CBER Reports CBER Annual Report, Performance, FDAMA, PDUFA, FDAAA, PREA
Biologics Regulated Products Allergenics, Blood & Blood Products, Cellular & Gene Therapy Products, Tissue & Tissue Products, Vaccines, Xenotransplantation
Contacts in the Center for Biologics Evaluation & Research (CBER) Consumer questions, manufacturer's assistance, media inquiries, technical questions, requesting speakers, establishment registration...
Jobs at the Center for Biologics Evaluation and Research (CBER)
Frequently Asked Questions about the Center for Biologics Evaluation and Research (CBER) and the Products CBER Regulates
Biologics Electronic Reading Room (eFOI) Documents frequently requested through the Freedom of Information Act.
|
|
|
|
|
|
|
|
RULES
- NONE |
|
|
NOTICES |
Meetings:
Incorporation of New Science Into Regulatory
Decisionmaking Within the
Center for Devices and
Radiological Health
6723767238 [E930114]
[TEXT] [PDF]
|
|
|
|
RULES |
New Animal Drugs for Use in
Animal Feeds:
Ractopamine; Tylosin
6691466915 [E929998]
[TEXT] [PDF]
|
|
NOTICES |
Filing of Food Additive
Petition:
Lallemand, Inc.
66979 [E929961]
[TEXT] [PDF]
International Conference on
Harmonisation:
Draft Guidance on Addendum to S6; Preclinical Safety
Evaluation of
Biotechnology-Derived
Pharmaceuticals S6(R1)
6698066981 [E929991]
[TEXT] [PDF]
Draft Guidance on Q4B Evaluation and Recommendation of
Pharmacopoeial Texts, etc.;
Annex 11 on Capillary
Electrophoresis General
Chapter
6698166982 [E929990]
[TEXT] [PDF]
Draft Guidance on Q4B Evaluation and Recommendation of
Pharmacopoeial Texts, etc.;
Annex 12 on Analytical
Sieving General Chapter
6698266983 [E929988]
[TEXT] [PDF]
Meetings:
Oncologic Drugs Advisory Committee
6698666987 [E929989]
[TEXT] [PDF]
Public Workshops:
Food and Drug Administration Clinical Trial
Requirements, Regulations,
Compliance and Good Clinical
Practices
6698866989 [E930017]
[TEXT] [PDF]
|
|
|
|
RULES |
Implantation or Injectable
Dosage Form New Animal
Drugs:
Florfenicol
6657366574 [E929875]
[TEXT] [PDF]
New Animal Drugs:
Change of Sponsor; Ketamine
66573 [E929888]
[TEXT] [PDF]
|
|
NOTICES |
|
|
|
|
RULES
- NONE |
|
|
NOTICES
- NONE |
|
|
|
|
RULES |
Implantation or Injectable
Dosage Form New Animal
Drugs:
Insulin
6604766048 [E929583]
[TEXT] [PDF]
New Animal Drugs; Change of
Sponsor's Name and Address
66047 [E929627]
[TEXT] [PDF]
|
|
NOTICES |
Debarment Order:
Peter Xuong Lam
6613366134 [E929715]
[TEXT] [PDF]
|
|
|
|
|
|